New Beginnings Treatment Center

In-Balance Transitional Living is a highly regarded young adult aftercare community located in Tucson, AZ, offering support and guidance to young men aged 17.5 to 28 who have completed primary treatment for substance abuse and co-occurring disorders. With a focus on the 12-step program, clinical sophistication, and life skills development, In-Balance Transitional Living aims to help these individuals maintain sobriety while transitioning into independent adulthood. With two campuses, In-Balance Transitional Living provides a unique and supportive environment for young men to thrive. The young adult program, situated in a residential neighborhood near the University of Arizona, offers a simulated independent living experience, while the collegiate recovery campus, located near the university and Pima Community College, provides a fraternity-like atmosphere. Through a combination of therapy, life skills training, and sober recreational activities, In-Balance Transitional Living empowers young men to lead fulfilling and sober lives.Generated from the website

Critical Path Institute, founded in 2005 in Tucson, Arizona, is an independent, non-profit organization dedicated to bringing scientists from the FDA, industry, and academia together to improve the path for innovative new drugs, diagnostic tests and devices to reach patients in need.Based in Arizona with offices in Tucson, Phoenix, and Rockville, Maryland, C-Path relies on three basic tenets in its approach to drug development: faster, safer and smarter. Our programs address scientific, safety and educational aspects of medical product development in support of the FDA's Critical Path Initiative. The overall goal of the Critical Path Initiative is to modernize the scientific process through which a potential human drug, biological product, or medical device is tested and developed. Our programs were developed with detailed input and participation from scientists from the FDA, industry and academia.Our contributors include key organizations and individuals from the public and private sectors at the local, regional and national levels. Since 2005, over $20 million in grants and $10 million in contributions has been received to support C-Path's work. In order to serve as a neutral and trusted third party for collaborators, C-Path does not accept monies from organizations that develop products regulated by the FDA or that would create a real or perceived conflict of interest. C-Path manages industrial consortia of companies willing to share pre-competitive knowledge and work in support of projects that are identified as high priority by the FDA and are in the interest of public health.